ArticleScientific reports2025
Baseline choroidal microvasculature dropout as a predictor of rapid global structural loss in open-angle glaucoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ocular Blood Flow in Eyes with Myopia and Glaucoma: From Pathophysiology to Clinical Implications.Journal of clinical medicine · 2026Review
- Relationship Between Parapapillary Microvasculature Dropout and Visual Field Defect in Glaucoma: A Cross-Sectional OCTA Analysis.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study included 102 open-angle glaucoma (OAG) eyes with or without a localized choroidal microvasculature dropout (CMvD) at the inferior hemiretina, matched for age (≤ 10 years), axial length (≤ 1 mm), and visual field severity (≤ 1dB), and with a minimum 2-year follow-up. Serial thickness [circumpapillary retinal nerve fiber layer (cpRNFLT) and macular ganglion cell-inner plexiform layer thickness (mGCIPLT)], and vessel density (VD) [circumpapillary (cpVD) and macular VD (mVD)] parameters were obtained. The rate of change in each parameter at both the superior (CMvD-unaffected) and inferior (CMvD-affected) hemiretina were compared between matched eyes with (CMvD+) and without CMvD (CMvD-). Clinical factors associated with the rate of change in each parameter both globally and at the CMvD-unaffected hemiretina were also evaluated. CMvD + eyes showed significantly faster rates of VD and thickness loss at both the CMvD-affected and -unaffected hemiretina. In addition, CMvD was significantly associated with rapid loss of both VD and thickness parameters globally and at the CMvD-unaffected superior hemiretina. In conclusion, OAG eyes with CMvD show significantly faster rates of VD and thickness loss at both the CMvD-affected and unaffected hemiretina. A localized CMvD is an independent predictor of globally rapid structural loss in OAG eyes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.